Genomic Profiling of Breast Cancer: A Multidisciplinary approach in early stage breast cancer treatment decisions - European Medical Journal

Genomic Profiling of Breast Cancer: A Multidisciplinary approach in early stage breast cancer treatment decisions

Oncology

Join Agendia for a Multidisciplinary Discussion on the Increasing Role of Genomic Profiling in Early Stage Breast Cancer

  • Understand the latest data supporting the utility of Agendia’s assays: MammaPrint® andBluePrint® for early-stage breast cancer patients
  • Review and appreciate the real-world impact of MammaPrint and BluePrint
  • Recommend genomic profiling for pre-and post-operative breast cancer treatment planning

This virtual webinar presentation featuring Dr. Cathy Graham & Dr. William Audeh was broadcast on 21st June 2022.

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now